The long-term objective of our research is to better understand the mechanisms underlying both normal and abnormal ocular motor and vestibular function in Huntington's Disease (HD). Our recent research has shown that patients with HD have selective deficits in generating """"""""volitional"""""""" saccades (e.g. antisaccades and predictive saccades) as well as defects in suppression of unwanted reflexive saccades in response to novel stimuli.
The first aim of the present proposal is to develop more subtle ways of testing and quantifying the higher level control of saccadic and also pursuit eye movements. A new saccade paradigm will be tested that measures the amplitude and latency of saccades while making sequences of saccades to a series of seen or remembered targets. We will also compare the gain and timing of smooth pursuit movements to stimuli that produce a more reflexive response (sudden movement of a full field stimulus) with stimuli that produce a more volitional response (tracking of a small target moving on a visually rich background). We expect HD patients to show deficits in more volitional pursuit.
The second aim i s to evaluate further postural and vestibular control in patients with HD. Using moving platform posturography, we will measure postural control in patients with HD and compare the results with measurement of their vestibulo-ocular reflex. We will test the hypothesis that the ataxia of HD patients is related to a disorder of central processing of vestibular information. All of our testing results will be correlated with results of tests of neurological and psychological function and MRI studies.

Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Faria, Andreia V; Ratnanather, J Tilak; Tward, Daniel J et al. (2016) Linking white matter and deep gray matter alterations in premanifest Huntington disease. Neuroimage Clin 11:450-460
Krause, Amanda; Mitchell, Claire; Essop, Fahmida et al. (2015) Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype. Am J Med Genet B Neuropsychiatr Genet 168:573-85
Ross, Christopher A; Pantelyat, Alex; Kogan, Jane et al. (2014) Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction. Mov Disord 29:1351-8
Hua, Jun; Unschuld, Paul G; Margolis, Russell L et al. (2014) Elevated arteriolar cerebral blood volume in prodromal Huntington's disease. Mov Disord 29:396-401
Unschuld, Paul G; Liu, Xinyang; Shanahan, Megan et al. (2013) Prefrontal executive function associated coupling relates to Huntington's disease stage. Cortex 49:2661-73
Aggarwal, Manisha; Duan, Wenzhen; Hou, Zhipeng et al. (2012) Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging. Neuroimage 60:2086-95
Lee, Youngjin; Morrison, Brett M; Li, Yun et al. (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443-8
Unschuld, Paul G; Edden, Richard A E; Carass, Aaron et al. (2012) Brain metabolite alterations and cognitive dysfunction in early Huntington's disease. Mov Disord 27:895-902
Guo, Zhihong; Rudow, Gay; Pletnikova, Olga et al. (2012) Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease. Mov Disord 27:1379-86
Fu, Jinrong; Jin, Jing; Cichewicz, Robert H et al. (2012) trans-(-)-?-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease. J Biol Chem 287:24460-72

Showing the most recent 10 out of 55 publications